• For every Cigarette there's a nicorette®

  • ActiveStop Login

    Health Care Professionals

    Search

  • Quitting
    • iPhone App
    • Women and Smoking
    • Budget Calculator
    • Stop Smoking Tips
    • Nicotine Myths
    • Truth about Quitting
    • Motivation test
    • Weight Control
  • Products
    • QuickMist
    • INVISIPATCH™
    • Inhalator
    • Gum
    • Lozenge
    • Microtab
    • Nasal Spray
    • Where to buy
  • Your Profile
  • ActiveStop
    • Welcome to ActiveStop
    • Help
    • iPhone App
  • Cut Down to Stop
    • 4 Steps to cut down
    • NICORETTE® Gum
    • NICORETTE® Inhalator
  • Home
  • About NICORETTE® QuickMist
  • Efficacy
    •  
      • Home
      • About NICORETTE® INVISIPATCH
      • About NICORETTE® QuickMist
        • Efficacy
        • Tolerability
        • Frequently asked questions
        • Dosage and administration
      • Product Range
      • Smoking hazards
      • How to support your customers
      • Product Information
      • Adverse Event Reporting
      • Services
        • Links
    •  
    • Related Links

      For more information on NICORETTE® QuickMist please download the SmPC

      For full product information, click here.

    • Efficacy

      When cravings arise…

      NICORETTE® QuickMist mouthspray is a new and unique format for fast craving relief. Acts fast to help smokers quit.1,2

      • Clinically proven to relieve cravings in just 60 seconds (p<0.001)1
      • 46% more effective at helping smokers quit compared with placebo at 4 weeks (p<0.05)2
      • 2.5 times more effective at helping smokers quit compared with placebo at 52 weeks (p<0.01)2

      Why smokers find cigarettes such a difficult relationship to break

      Cigarettes are so addictive because of the rapid delivery of a high dose of nicotine to the brain. Due to the short half life of nicotine, smokers require to smoke regularly to maintain a certain level. When nicotine levels drop the cravings for the next cigarette begin.3

      Plasma (venous) nicotine profile during 7 hours of cigarette smoking (1 cigarette per hour)

      Reinforcing this desired effect of nicotine with each cigarette soon becomes addictive.3

      NICORETTE® QuickMist provides rapid absorption of nicotine

      Due to its rapid absorption through the oral mucosa, the time to reach maximum plasma nicotine concentration following a single dose is significantly shorter for NICORETTE® QuickMist than with NiQuitin 4 mg lozenge.

      Single dose nicotine pharmacokinetics

      NICORETTE® QuickMist demonstrated an increase in nicotine level with peak plasma levels reached in less than 10 minutes. In total 58% more nicotine was absorbed with NICORETTE® QuickMist than with NiQuitin 4mg lozenge during the first 10 minutes.5

      Smokers can find cravings for nicotine overwhelming

      Cravings can strike especially at so called “trigger moments”, making smoking cessation an even bigger challenge. Situations linked to smoking such as at home watching TV, driving the car and socialising may make it difficult to quit.6 Other factors that may influence the smokers’ willpower are

      • when under the influence of alcohol7
      • where people are smoking and cigarettes are available7
      • when particularly stressed7
      • in the afternoons and evenings, when withdrawal symptoms may be more frequent and more severe8,9

      NICORETTE® QuickMist acts fast on cravings

      With NICORETTE® QuickMist you can help your customer in those critical first minutes of a craving when they could cause lapse: NICORETTE® QuickMist is clinically proven to relieve cravings in just 60 seconds with 2x1mg/sprays (p<0.001). It targets craving by providing relief up to 3 times faster than NiQuitin 4mg lozenge (p<0.001).1

      Cravings relief in an open label study: NICORETTE® QuickMist 2x1 mg vs. NiQuitin lozenge 4mg

      NICORETTE® QuickMist for short and long term efficacy

      NICORETTE® QuickMist provides efficacy to help your customer remain abstinent in the long term. As shown in the phase III study NICORETTE® QuickMist proved to be 46% more effective at helping smokers quit vs. placebo at 4 weeks (p<0.05). With NICORETTE® QuickMist your customers are 2.5 times more likely to quit smoking compared to placebo at 52 weeks (p<0.01).5

      Sustained abstinence in all smokers

      How your customers can use NICORETTE® QuickMist effectively

      How to Open:12

      • Use your thumb to slide down the button until it can be pushed lightly inwards. Do not push too hard
      • While pushing in, slide upwards to unlock the top of the dispenser. Then release the button

      How to prime:

      • If you are using NICORETTE® QuickMist for the first time or if you have not used the spray for 2 days, you must first prime the spray pump
      • Point the spray safely away from you and press the top of the QuickMist firmly with your index finger several times until a fine spray appears

      How to use:

      • Point the spray nozzle towards the open mouth, holding it as close as possible
      • Press the top of the dispenser firmly to release one spray into the mouth, avoiding the lips
      • To avoid getting spray down the throat, don't swallow or inhale while spraying
      • For best results, don't swallow for a few seconds after spraying
      • Use 1 or 2 sprays when cigarettes normally would have been smoked or if cravings emerge button spray nozzle button spray nozzle button spray nozzle button spray nozzle

      What you can expect:

      • When the spray is released into the mouth, you may initially experience a fresh mint sensation
      • One of the most commonly reported side effects is hiccups, the majority of which are mild

      1.
      Hansson A, et al. Craving Relief With A Novel Nicotine Mouth Spray Form Of Nicotine Replacement Therapy. Poster Presented at SRNT, Feb 16-19th, 2011, Toronto, Canada.
      2.
      Tonnesen P, et al. Efficacy and safety of a novel nicotine mouth spray in smoking cessation. A randomized, placebo-controlled, double-blind, multi-center study with a 52-week follow-up. Poster Presented at SRNT, Feb 16-19th, 2011, Toronto, Canada.
      3.
      Nicotine addiction in Britain: a report of the Tobacco Advisory Group of the Royal College of Physicians. London Royal College of Physicians 2000.
      4.
      Russell MAH, et al. BMJ 1976; 1:1043-1046.
      5.
      Kraiczi H, et al. Single-Dose Pharmacokinetics Of Nicotine With A Novel Mouth Spray For Nicotine Replacement Therapy. Poster Presented at SRNT, Feb 16-19th, 2011, Toronto, Canada.
      6.
      Van Gucht D, et al. J Behav Ther & Exp Psychiat 2010; 41: 172-177.
      7.
      McRobbie H, McEwan A, NICE. Royal Pharmaceutical Society of Great Britain and Pharmacy/HealthLink. 2005.
      8.
      Fagerstrom KO et al. Psychopharmacology, 1993; 111: 271-277.
      9.
      Shiffman S, et al. J Consult Clin Pyschol 1996; 64: 366 379.
      10.
      Ferguson SG, Shiffman S. J Substance Abuse Treatment 2009; 36: 235-243.
      11.
      Data on File
      12.
      NICORETTE® QuickMist Patient Information Leaflet.

The NICORETTE® range includes NICORETTE® QuickMist mouthspray,  NICORETTE® Freshmint lozenge, NICORETTE® Gums, NICORETTE® Patches, NICORETTE® Inhalators, NICORETTE® Microtab and NICORETTE® Nasal spray. NICORETTE® is a stop smoking aid. Contains nicotine. Always read the label. Requires willpower.

    • Quick links
    • Home
    • Quitting
    • Products
    • ActiveStop
    • Cut down to stop
    • Privacy Policy
    • Legal Notice
    • Terms of Use
    • Contact us
    • Press
    • Site Map
  • This site is best viewed with the following web browsers: Internet Explorer Version 7, Internet Explorer Version 6, Firefox Version 2.0 and Safari
    © McNeil Healthcare (UK) Limited 2011
    This site is published by McNeil Healthcare (UK) Limited which is solely responsible for its contents. It is intended for Healthcare Professionals in the UK.

    Site last updated 09 May 2012.